July 02, 2015

Tadros v. Celladon Corporation et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. October 11, 2016

    Celladon Ditches Investor Suit Over Mydicar Trial Claims

    A California federal judge has tossed a proposed class action targeting pharmaceutical maker Celladon Corp. and two executives for allegedly misleading shareholders about the success of a heart therapy drug prior to suspending development, saying the investor heading the suit hadn't shown any false statements.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS